Related Experiment Video
Updated: Feb 24, 2026

10:42
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
Published on: June 15, 2021
5.6K
A microfluidic platform for the high-throughput study of pathological cardiac hypertrophy
Hesam Parsa1, Bryan Z Wang, Gordana Vunjak-Novakovic
1Department of Biomedical Engineering, Columbia University, 622 west 168th St., New York, NY 10032, USA. gv2131@columbia.edu.
Lab on a Chip
|August 24, 2017
Summary
Researchers developed a novel microfluidic platform to study cardiac hypertrophy. This high-throughput system accurately models volume overload in engineered heart tissues, revealing pathological remodeling mechanisms.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Microfluidics
Background:
- Current in vitro models inadequately replicate cardiac hypertrophy mechanisms due to volume overload.
- Understanding these mechanisms is crucial for developing effective treatments for heart conditions.
Purpose of the Study:
- To develop and validate a novel pneumatic microfluidic platform for high-throughput cardiac hypertrophy studies.
- To investigate the pathological remodeling of engineered cardiac tissues under sustained volume overload.
Main Methods:
- Development of a reusable pneumatic microfluidic platform for mechanical stimulation of cardiac micro-tissues (μtissues).
- High-throughput, reproducible manipulation and real-time on-chip analysis of μtissues over several weeks.
- Application of pneumatic loading to recapitulate volume overload pathology in 3D cardiac tissues.
Main Results:
- The platform enabled robust and repetitive mechanical stimulation of cardiac μtissues.
- Pneumatic loading faithfully mimicked volume overload pathology observed in native heart tissue.
- Sustained volume overload induced pathological cardiac remodeling and fetal gene program upregulation in a dose-dependent manner.
Conclusions:
- The developed microfluidic platform is a powerful tool for studying cardiac hypertrophy and volume overload.
- This model provides new insights into the mechanisms of pathological cardiac remodeling.
- The platform facilitates high-throughput, reproducible, and mechanistically relevant cardiac research.

